Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

1.

Assessment of receptor occupancy-over-time of two dopamine transporter inhibitors by [(11)C]CIT and target controlled infusion.

Eriksson O, Långström B, Josephsson R.

Ups J Med Sci. 2011 May;116(2):100-6. doi: 10.3109/03009734.2011.563878. Epub 2011 Mar 28.

PMID:
21443419
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Non-hybridization saturable mechanisms play a role in the uptake of (68)Ga-Labeled LNA-DNA mixmer antisense oligonucleotides in rats.

Lendvai G, Monazzam A, Velikyan I, Eriksson B, Josephsson R, Långström B, Bergström M, Estrada S.

Oligonucleotides. 2009 Sep;19(3):223-32. doi: 10.1089/oli.2009.0192.

PMID:
19732020
[PubMed - indexed for MEDLINE]
3.

The risk of exaggerated risk aversion-a life and death struggle for molecular imaging.

Långström B, Grahnen A, Honoré PH, Borlak J, Bergstrom M, Nielsen B, Vanderheyden J, Watanabe Y, Josephsson R, Høilund-Carlsen PF, Schwaiger M, Larson SM, Goldenberg DM, Melzer A, Engler H, Hicks R, Sundin A, Seppänen M, Hedenstierna G, Nordberg A, Brooks D.

Eur J Nucl Med Mol Imaging. 2009 Oct;36(10):1693-4. doi: 10.1007/s00259-009-1190-1. No abstract available.

PMID:
19618184
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.

Monazzam A, Razifar P, Ide S, Rugaard Jensen M, Josephsson R, Blomqvist C, Langström B, Bergström M.

Nucl Med Biol. 2009 Apr;36(3):335-42. doi: 10.1016/j.nucmedbio.2008.12.009.

PMID:
19324279
[PubMed - indexed for MEDLINE]
5.

Modeling spheroid growth, PET tracer uptake, and treatment effects of the Hsp90 inhibitor NVP-AUY922.

Bergstrom M, Monazzam A, Razifar P, Ide S, Josephsson R, Langstrom B.

J Nucl Med. 2008 Jul;49(7):1204-10. doi: 10.2967/jnumed.108.050799. Epub 2008 Jun 13.

PMID:
18552146
[PubMed - indexed for MEDLINE]
Free Article
6.

A computerized infusion pump for control of tissue tracer concentration during positron emission tomography in vivo pharmacokinetic/pharmacodynamic measurements.

Eriksson O, Wallberg A, Syvänen S, Josephsson R, Långström B, Bergström M.

BMC Med Phys. 2008 May 30;8:2. doi: 10.1186/1756-6649-8-2.

PMID:
18513382
[PubMed]
Free PMC Article
7.

Positron emission tomography and target-controlled infusion for precise modulation of brain drug concentration.

Eriksson O, Josephsson R, Långstrom B, Bergström M.

Nucl Med Biol. 2008 Apr;35(3):299-303. doi: 10.1016/j.nucmedbio.2007.12.003.

PMID:
18355685
[PubMed - indexed for MEDLINE]
8.

Application of the multicellular tumour spheroid model to screen PET tracers for analysis of early response of chemotherapy in breast cancer.

Monazzam A, Josephsson R, Blomqvist C, Carlsson J, Långström B, Bergström M.

Breast Cancer Res. 2007;9(4):R45.

PMID:
17659092
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Multicellular tumour spheroid as a model for evaluation of [18F]FDG as biomarker for breast cancer treatment monitoring.

Monazzam A, Razifar P, Simonsson M, Qvarnström F, Josephsson R, Blomqvist C, Långström B, Bergström M.

Cancer Cell Int. 2006 Mar 23;6:6.

PMID:
16556298
[PubMed]
Free PMC Article
10.

A new, fast and semi-automated size determination method (SASDM) for studying multicellular tumor spheroids.

Monazzam A, Razifar P, Lindhe O, Josephsson R, Långström B, Bergström M.

Cancer Cell Int. 2005 Nov 14;5:32.

PMID:
16283948
[PubMed]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk